XML 48 R33.htm IDEA: XBRL DOCUMENT v3.21.2

Business Segment Information Business Segment Information (Tables)

6 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Financial information for each of our segments is presented in the following table:

						Three Months Ended September 30,												Six Months Ended September 30,
						2021						2020						2021						2020
Revenues:												(*as adjusted)												(*as adjusted)
Healthcare						$	744,134					$	470,927					$	1,346,951					$	870,585
Applied Sterilization Technologies						204,892						169,547						413,794						321,909
Life Sciences						132,327						115,658						253,798						232,570
Dental						$	115,632					—						$	150,864					$	—
Total revenues						$	1,196,985					$	756,132					$	2,165,407					$	1,425,064
Operating income (loss):
Healthcare						$	160,390					$	104,796					$	296,550					$	188,968
Applied Sterilization Technologies						99,789						76,835						201,716						140,790
Life Sciences						57,519						46,433						106,607						94,894
Dental						32,392						—						42,511						—
Corporate						(71,552)						(58,155)						(146,612)						(110,522)
Total operating income before adjustments						$	278,538					$	169,909					$	500,772					$	314,130
Less: Adjustments
Amortization of acquired intangible assets (1)						$	74,791					$	21,955					$	116,531					$	39,455
Acquisition and integration related charges (2)						17,404						1,135						158,400						2,421
Redomiciliation and tax restructuring costs (3)						159						384						110						554
Net (gain) loss on divestiture of businesses (1)						(15)						(5)						404						5
Amortization of inventory and property "step up" to fair value (1)						69,486						714						94,276						1,317
COVID-19 incremental costs (4)						—						4,539						—						13,209
Restructuring charges (5)						210						(76)						224						90
Total operating income						$	116,503					$	141,263					$	130,827					$	257,079

Revenue from External Customers by Products and Services [Table Text Block]

						Three Months Ended September 30,												Six Months Ended September 30,
						2021						2020						2021						2020
Healthcare:
Capital equipment						$	202,405					$	131,673					$	353,295					259,755
Consumables						270,089						122,797						476,781						206,551
Service						271,640						216,457						516,875						404,279
Total Healthcare Revenues						$	744,134					$	470,927					$	1,346,951					$	870,585
Applied Sterilization Technologies Service Revenues						$	204,892					$	169,547					$	413,794					$	321,909
Life Sciences:
Capital equipment						$	34,186					$	29,241					$	66,931					$	59,671
Consumables						61,748						55,793						118,284						114,635
Service						36,393						30,624						68,583						58,264
Total Life Sciences Revenues						$	132,327					$	115,658					$	253,798					$	232,570
Dental Revenues						$	115,632					$	—					$	150,864					$	—
Total Revenues						$	1,196,985					$	756,132					$	2,165,407					$	1,425,064

Revenue from External Customers by Geographic Areas [Table Text Block]

			Three Months Ended September 30,												Six Months Ended September 30,
			2021						2020						2021						2020
Revenues:
Ireland			$	20,046					$	17,090					$	41,991					$	31,463
United States			852,497						549,449						1,531,747						1,041,157
Other locations			324,442						189,593						591,669						352,444
Total Revenues			$	1,196,985					$	756,132					$	2,165,407					$	1,425,064

						September 30, 2021						March 31, 2021
Property, Plant, and Equipment, Net
Ireland						$	53,784					52,140
United States						881,069						673,784
Other locations						576,402						509,476
Property, Plant, and Equipment, Net						$	1,511,255					$	1,235,400

Reconciliation of Assets from Segment to Consolidated

Assets include the current and long-lived assets directly attributable to the segment based on the management of the location or on utilization. Certain corporate assets were allocated to the reportable segments based on revenues. Assets attributed to sales and distribution locations are only allocated to the Healthcare and Life Sciences segments.

Individual facilities, equipment, and intellectual properties are utilized for production by both the Healthcare and Life Sciences segments at varying levels over time. As a result, an allocation of total assets, capital expenditures, and depreciation and amortization is not meaningful to the individual performance of the Healthcare and Life Sciences segments. Therefore, their respective amounts are reported together.

						September 30, 2021						March 31, 2021
Assets:
Healthcare and Life Sciences						$	5,398,177					$	3,600,182
Applied Sterilization Technologies						3,029,090						2,974,289
Dental						1,175,354						—
Cantel related goodwill not yet allocated (1)						2,149,827						—
Total assets						$	11,752,448					$	6,574,471

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph a
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration